{"id":63874,"date":"2025-09-30T18:42:02","date_gmt":"2025-09-30T16:42:02","guid":{"rendered":"https:\/\/ticker-noticiasep.microcontenidos.com\/NoticiaRSS.vbhtml?user=FRND562DLP&amp;cod=20250930164202"},"modified":"2025-09-30T18:42:02","modified_gmt":"2025-09-30T16:42:02","slug":"mundo-datajoint-cierra-una-financiacion-inicial-de-49-millones-de-dolares-2","status":"publish","type":"post","link":"https:\/\/webciudadana.net\/?p=63874","title":{"rendered":"Mundo: DataJoint cierra una financiaci\u00f3n inicial de 4,9 millones de d\u00f3lares (2)"},"content":{"rendered":"\n<p>(Informaci\u00f3n remitida por la empresa firmante)<\/p>\n<p>\nPharmStars es la aceleradora de empresas emergentes de salud digital, centrada en la industria farmac\u00e9utica y basada en miembros. Gracias a nuestra experiencia en el sector farmac\u00e9utico, empresas emergentes, salud digital e innovaci\u00f3n, comprendemos los desaf\u00edos a los que se enfrentan las empresas farmac\u00e9uticas y las empresas emergentes al buscar colaboraci\u00f3n. Nuestro programa PharmaUTM apoya a las empresas emergentes de salud digital y a nuestros miembros farmac\u00e9uticos para \u00abcerrar la brecha entre la industria farmac\u00e9utica y las empresas emergentes, lo que se traduce en un mayor \u00e9xito y una adopci\u00f3n m\u00e1s r\u00e1pida de soluciones \u00abm\u00e1s all\u00e1 de la mol\u00e9cula\u00bb. M\u00e1s informaci\u00f3n en www.PharmStars.com. Para consultas de medios:<\/p>\n<p>\nDataJoint<\/p>\n<p>\nJim Olson, consejero delegado<\/p>\n<p>\ninfo@datajoint.com<\/p>\n<p>\nNina Capital<\/p>\n<p>\npress@nina.capital<\/p>\n<p>\nInoca Capital Partners<\/p>\n<p>\ninfo@inocacapital.com<\/p>\n<p>\nCapital Factory<\/p>\n<p>\npress@capitalfactory.com<\/p>\n<p>\nLogo &#8212; https:\/\/mma.prnewswire.com\/media\/2783095\/DataJoint_Logo_Logo.jpg<\/p>\n<p> View original content:https:\/\/www.prnewswire.com\/news-releases\/datajoint-cierra-una-financiacion-inicial-de-4-9-millones-de-dolares-302570112.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Informaci\u00f3n remitida por la empresa firmante) PharmStars es la aceleradora de empresas emergentes de salud digital, centrada en la industria farmac\u00e9utica y basada en miembros. Gracias a nuestra experiencia en el sector farmac\u00e9utico, empresas emergentes, salud digital e innovaci\u00f3n, comprendemos los desaf\u00edos a los que se enfrentan las empresas farmac\u00e9uticas y las empresas emergentes al [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-63874","post","type-post","status-publish","format-standard","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/63874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63874"}],"version-history":[{"count":1,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/63874\/revisions"}],"predecessor-version":[{"id":63884,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/63874\/revisions\/63884"}],"wp:attachment":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}